Hypogonadotrophic Hypogonadism in Type 2 Diabetes, Obesity and the Metabolic Syndrome

E-ISSN： 1875-5666|8|8|816-828

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.8, Iss.8, 2008-12, pp. : 816-828

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cortisol Regulation in Patients with Type 2 Diabetes and the Metabolic Syndrome

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 4, 2012-12 ,pp. : 245-256

Bentham Science Publishers

Access to resources Recommend Favorite

Obesity, Metabolic Syndrome, Diabetes and Arterial Hypertension

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 6, Iss. 4, 2006-08 ,pp. : 407-423

Bentham Science Publishers

Access to resources Recommend Favorite

Phospholipid Transfer Protein in Diabetes, Metabolic Syndrome and Obesity

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 14, Iss. 2, 2014-08 ,pp. : 149-153

Bentham Science Publishers

Access to resources Recommend Favorite

Type 2 Diabetes: An Atherothrombotic Syndrome

Current Molecular Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 323-332

Bentham Science Publishers

Access to resources Recommend Favorite

Obesity stigma: A newly recognized barrier to comprehensive and effective type 2 diabetes management

By Teixeira M. Elizabeth Budd Geraldine M.

Journal of the American Academy of Nurse Practitioners, Vol. 22, Iss. 10, 2010-10 ,pp. : 527-533

Blackwell Publishing

Access to resources Recommend Favorite